These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26471181)

  • 1. Standardized application of yeast bioluminescent reporters as endocrine disruptor screen for comparative analysis of wastewater effluents from membrane bioreactor and traditional activated sludge.
    Wang J; Eldridge M; Menn FM; Dykes T; Sayler G
    Ecotoxicology; 2015 Dec; 24(10):2088-99. PubMed ID: 26471181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of endocrine disrupting chemicals in a large scale membrane bioreactor plant combined with anaerobic-anoxic-oxic process for municipal wastewater reclamation.
    Wu C; Xue W; Zhou H; Huang X; Wen X
    Water Sci Technol; 2011; 64(7):1511-8. PubMed ID: 22179650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of environmental endocrine disrupting chemicals using the E-screen method and stir bar sorptive extraction in wastewater treatment plant effluents.
    Bicchi C; Schilirò T; Pignata C; Fea E; Cordero C; Canale F; Gilli G
    Sci Total Environ; 2009 Mar; 407(6):1842-51. PubMed ID: 19101021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive study of endocrine disrupting compounds using grab and passive sampling at selected wastewater treatment plants in South East Queensland, Australia.
    Tan BL; Hawker DW; Müller JF; Leusch FD; Tremblay LA; Chapman HF
    Environ Int; 2007 Jul; 33(5):654-69. PubMed ID: 17331577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence, fate and environmental risk assessment of endocrine disrupting compounds at the wastewater treatment works in Pietermaritzburg (South Africa).
    Manickum T; John W
    Sci Total Environ; 2014 Jan; 468-469():584-97. PubMed ID: 24056449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents.
    Maletz S; Floehr T; Beier S; Klümper C; Brouwer A; Behnisch P; Higley E; Giesy JP; Hecker M; Gebhardt W; Linnemann V; Pinnekamp J; Hollert H
    Water Res; 2013 Mar; 47(4):1545-57. PubMed ID: 23305681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the in vitro estrogenicity of emerging bisphenol analogs and their respective estrogenic contributions in municipal sewage sludge in China.
    Ruan T; Liang D; Song S; Song M; Wang H; Jiang G
    Chemosphere; 2015 Apr; 124():150-5. PubMed ID: 25548037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical approach for monitoring endocrine-disrupting compounds in urban waste water treatment plants.
    Roda A; Mirasoli M; Michelini E; Magliulo M; Simoni P; Guardigli M; Curini R; Sergi M; Marino A
    Anal Bioanal Chem; 2006 Jun; 385(4):742-52. PubMed ID: 16741774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine disrupting activities in sewage effluent and river water determined by chemical analysis and in vitro assay in the context of granular activated carbon upgrade.
    Grover DP; Balaam J; Pacitto S; Readman JW; White S; Zhou JL
    Chemosphere; 2011 Sep; 84(10):1512-20. PubMed ID: 21546050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocrine disrupting activity of surface waters and of wastewater treatment plant effluents in relation to chlorination.
    Schilirò T; Pignata C; Rovere R; Fea E; Gilli G
    Chemosphere; 2009 Apr; 75(3):335-40. PubMed ID: 19155045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the removal efficiency of endocrine disrupting compounds in pilot scale sewage treatment processes.
    Lee J; Lee BC; Ra JS; Cho J; Kim IS; Chang NI; Kim HK; Kim SD
    Chemosphere; 2008 Apr; 71(8):1582-92. PubMed ID: 18158170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Analysis of Endocrine-Disrupting Compounds Using BLYES and BLYAS Bioluminescent Yeast Bioassays.
    Xu T; Young A; Narula J; Sayler G; Ripp S
    Methods Mol Biol; 2020; 2081():29-41. PubMed ID: 31721116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modeling for estrogenic activity prediction of 17β-estradiol and 17α-ethynylestradiol mixtures in wastewater treatment plants effluent.
    Ting YF; Praveena SM; Aris AZ; Ismail SNS; Rasdi I
    Ecotoxicology; 2017 Dec; 26(10):1327-1335. PubMed ID: 28975452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of environmental endocrine disrupting activities using recombinant yeast assay in wastewater treatment plant effluents.
    Li J; Wang Z; Ma M; Peng X
    Bull Environ Contam Toxicol; 2010 May; 84(5):529-35. PubMed ID: 20407748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of environmental endocrine disrupting activities in wastewater treatment plant effluents using recombinant yeast assays incorporated with exogenous metabolic activation system.
    Li J; Chen M; Wang Z; Ma M; Peng X
    Biomed Environ Sci; 2011 Apr; 24(2):132-9. PubMed ID: 21565684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect-based assessment of toxicity removal during wastewater treatment.
    Välitalo P; Massei R; Heiskanen I; Behnisch P; Brack W; Tindall AJ; Du Pasquier D; Küster E; Mikola A; Schulze T; Sillanpää M
    Water Res; 2017 Dec; 126():153-163. PubMed ID: 28941401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of estrogenic compounds in wastewater effluent.
    Nakada N; Nyunoya H; Nakamura M; Hara A; Iguchi T; Takada H
    Environ Toxicol Chem; 2004 Dec; 23(12):2807-15. PubMed ID: 15648753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence, identification and removal of microplastic particles and fibers in conventional activated sludge process and advanced MBR technology.
    Lares M; Ncibi MC; Sillanpää M; Sillanpää M
    Water Res; 2018 Apr; 133():236-246. PubMed ID: 29407704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.